论文部分内容阅读
回顾性分析2014年1月至2015年5月间在我院的难治性糖尿病患者58例,其中T_2DM患者50例,T_2DM患者8例,并分别选取同期住院相匹配的T_2DM患者60例,T_1DM患者8例分别作为观察组和对照组,观察组为双C组,对照组为CSⅡ组。结果观察组的血糖达标时间明显要少(P<0.05),低血糖轻住院费用无增加。结论对于难治性糖尿病,双C方案更安全、快速、便捷,值得临床推广应用。
Fifty - eight patients with refractory diabetes mellitus in our hospital from January 2014 to May 2015 were retrospectively analyzed, including 50 T 2DM patients and 8 T 2 DM patients. Sixty T 2DM patients with matched T 1DM Eight patients were treated as observation group and control group respectively. Observation group was double C group and control group was CSⅡ group. Results The observation group had significantly lower blood glucose compliance time (P <0.05) and no hypoglycemia hospitalization cost. Conclusions For refractory diabetes, double C regimen is safer, faster and more convenient and worthy of clinical application.